Several potential urinary and plasma biomarkers for ADPKD have recently been reported, including NGAL [22], MCP-1 [24], [34], KIM-1 [23], [24], CD-14 and copeptin [35]. The gene discussed is CCL2; the disease is autosomal dominant polycystic kidney disease.